Funding, News and Announcements
» Go to news mainCDRD and MS Society of Canada seek research projects
Posted by Suman Jha on
September 12, 2016
in
Research Funding
The Centre for Drug Research and Development (CDRD) and the Multiple Sclerosis Society of Canada (MSSC) are continuing their partnership aimed at accelerating preclinical development of novel therapies for Multiple Sclerosis (MS). To achieve this goal, the organizations are seeking pre-proposals from investigators who are working on research projects aimed at developing new disease-modifying therapies for progressive MS. Such therapies may include novel approaches to promote remyelination, repair existing damage and/or protecting neurons to positively impact the progressive forms of the disease.
Click here to access the full Request for Pre-Proposals.
Recent News
- Congressionally Directed Medical Research Programs
- Update on CIHR Project Grants
- Federation for the Humanities and Social Sciences Congress
- Who Owns my Intellectual Property at Dalhousie?
- NSERC Discovery Horizons Pilot Program Webinar
- US Department of Defense – The Peer Reviewed Cancer Research Program
- Pfizer: New funding opportunities
- NRC‑IRAP